Genedrive (GDR) RNS Announcements

Add to Alert list
Date Time Source Announcement
15 Apr 2020 11:00 AM
RNS
Price Monitoring Extension
14 Apr 2020 09:06 AM
RNS
Second Price Monitoring Extn
14 Apr 2020 09:00 AM
RNS
Price Monitoring Extension
14 Apr 2020 07:01 AM
RNS
Holding(s) in Company
14 Apr 2020 07:00 AM
RNS
Holding(s) in Company
31 Mar 2020 11:52 AM
RNS
Holding(s) in Company
30 Mar 2020 02:01 PM
RNS
Holding(s) in Company
30 Mar 2020 11:06 AM
RNS
Second Price Monitoring Extn
30 Mar 2020 11:00 AM
RNS
Price Monitoring Extension
25 Mar 2020 07:00 AM
RNS
Business Update and SARS-COV-2 tests development
04 Mar 2020 03:33 PM
RNS
Grant of options
13 Feb 2020 09:53 AM
RNS
Holding(s) in Company
11 Feb 2020 04:00 PM
RNS
Director/PDMR Shareholding
06 Feb 2020 04:30 PM
RNS
Holding(s) in Company
05 Feb 2020 05:38 PM
RNS
Director/PDMR Shareholding
05 Feb 2020 05:32 PM
RNS
Director/PDMR Shareholding
05 Feb 2020 04:45 PM
RNS
Holding(s) in Company
05 Feb 2020 07:15 AM
EQS
genedrive plc (GDR): Western market progress bu...
04 Feb 2020 04:25 PM
RNS
Director/PDMR Shareholding
04 Feb 2020 02:06 PM
RNS
Second Price Monitoring Extn
04 Feb 2020 02:00 PM
RNS
Price Monitoring Extension
04 Feb 2020 07:00 AM
RNS
Half-year Report
15 Jan 2020 07:00 AM
RNS
Notice of Results
11 Dec 2019 05:24 PM
RNS
Holding(s) in Company
11 Dec 2019 10:06 AM
RNS
Holding(s) in Company
05 Dec 2019 11:30 AM
RNS
Additional Listing
03 Dec 2019 07:00 AM
RNS
AIHL assay kit demonstrates high clinical accuracy
27 Nov 2019 04:23 PM
RNS
Result of AGM
22 Nov 2019 02:41 PM
RNS
Director/PDMR Shareholding
21 Nov 2019 12:30 PM
EQS
genedrive plc (GDR): Regulatory hurdle leaped: ...
18 Nov 2019 07:00 AM
RNS
Antibiotic Induced Hearing Loss Assay CE marking
06 Nov 2019 07:00 AM
RNS
Notice of AGM and Change of Auditors
28 Oct 2019 07:30 AM
EQS
genedrive plc (GDR): Acceleration of news flow ...
22 Oct 2019 03:07 PM
RNS
Holding(s) in Company
22 Oct 2019 03:06 PM
RNS
Holding(s) in Company
07 Oct 2019 07:00 AM
RNS
NHS Ethics approval for use of AIHL test in trials
03 Oct 2019 07:00 AM
RNS
Final Results
09 Sep 2019 07:00 AM
RNS
Notice of Results
18 Jul 2019 07:30 AM
EQS
genedrive plc (GDR): Hepatitis C market frustra...
18 Jul 2019 07:00 AM
RNS
Director/PDMR Shareholding
09 Jul 2019 07:00 AM
RNS
Trading Update
08 Apr 2019 10:53 AM
EQS
genedrive plc (GDR): First commercial sales in ...
05 Apr 2019 08:29 AM
RNS
Director/PDMR Shareholding
28 Mar 2019 07:00 AM
RNS
Half-year Report
16 Jan 2019 01:21 PM
RNS
Holding(s) in Company
15 Jan 2019 07:00 AM
RNS
Trading update
31 Dec 2018 11:30 AM
RNS
Result of AGM
12 Dec 2018 07:49 AM
RNS
Holding(s) in Company
11 Dec 2018 07:15 AM
EQS
genedrive plc (GDR): Accelerating into fiscal 2...
10 Dec 2018 04:44 PM
RNS
Holding(s) in Company

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

UK 100

Latest directors dealings